Engineers Gate Manager’s ADMA Biologics ADMA Stock Holding History

Engineers Gate Manager’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$556K	Sell	66,482 -40,682	-38%	-$371K	0.01%	1442
2026 Q1	$966K	Buy	+107,164	New	+$1.69M	0.01%	1072
2025 Q4	–	Sell	-69,708	Closed	-$1.02M	–	2058
2025 Q3	$1.02M	Sell	69,708 -11,617	-14%	-$199K	0.01%	1135
2025 Q2	$1.48M	Buy	81,325 +40,091	+97%	+$818K	0.02%	900
2025 Q1	$818K	Sell	41,234 -8,754	-18%	-$151K	0.01%	1183
2024 Q4	$857K	Buy	+49,988	New	+$940K	0.01%	1107
2024 Q3	–	Sell	-73,968	Closed	-$827K	–	2077
2024 Q2	$827K	Buy	73,968 +34,548	+88%	+$290K	0.02%	984
2024 Q1	$260K	Buy	+39,420	New	+$215K	0.01%	1533
2021 Q2	–	Sell	-34,170	Closed	-$60K	–	1564
2021 Q1	$60K	Sell	34,170 -17,600	-34%	-$40.3K	﹤0.01%	1738
2020 Q4	$101K	Sell	51,770 -500	-1%	-$1.05K	﹤0.01%	1585
2020 Q3	$125K	Buy	+52,270	New	+$143K	0.01%	1518

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Engineers Gate Manager's ADMA Position: Q2 2026 in Review

Engineers Gate Manager reduced its ADMA Biologics (ADMA) stake by 38% in Q2 2026, selling an estimated $371K and leaving 66,482 shares worth $556K. The position accounts for 0.01% of the portfolio, ranked #1442.

Engineers Gate Manager first reported a position in ADMA in Q3 2020 and has held it in 11 quarters since. The position peaked at $1.48M in Q2 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

Engineers Gate Manager held 66,482 shares of ADMA Biologics worth $556K as of Q2 2026.
Engineers Gate Manager sold 40,682 ADMA Biologics shares in Q2 2026, an estimated $371K.
ADMA Biologics made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1442 holding.
Engineers Gate Manager first reported a position in ADMA Biologics in Q3 2020 and has held it in 11 quarters since.
Engineers Gate Manager's ADMA Biologics position peaked at $1.48M in Q2 2025.
323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.